Leerink Partners Initiates Coverage On Teladoc Health with Market Perform Rating, Announces Price Target of $17
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners analyst Michael Cherny initiates coverage on Teladoc Health (TDOC) with a Market Perform rating and a price target of $17.

February 26, 2024 | 12:39 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Leerink Partners initiated coverage on Teladoc Health with a Market Perform rating and a price target of $17.
The initiation of coverage by Leerink Partners with a Market Perform rating and a specific price target provides investors with a new professional analysis to consider. However, the 'Market Perform' rating suggests that the analyst believes TDOC will perform in line with the market, which does not imply a strong bullish or bearish stance. Therefore, the short-term impact on the stock price might be neutral, as the market absorbs this new information and aligns it with existing expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100